Increased c‑SRC expression is involved in acquired resistance to lenvatinib in hepatocellular carcinoma.

Authors:
Takahashi M; Araki T; Yashima H; Nagamine A; Nagano D and 1 more

Journal:
Oncol Lett

Publication Year: 2023

DOI:
10.3892/ol.2023.14116

PMCID:
PMC10654551

PMID:
38020292

Journal Information

Full Title: Oncol Lett

Abbreviation: Oncol Lett

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"availability of data and materials the raw mass spectrometry data and peptide/protein identification results generated and/or analyzed during the current study are available in the jpost repository https://repository jpostdb org/entry/jpst002307"

Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"This work was supported by JSPS KAKENHI (grant no. JP18K06743)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025